Table of Content

1 Fostamatinib Market Overview
1.1 Product Overview and Scope of Fostamatinib
1.2 Fostamatinib Segment by Type
1.2.1 Global Fostamatinib Market Value Comparison by Type (2024-2034)
1.2.2 Tavalisse
1.2.3 Tavlesse
1.3 Fostamatinib Segment by Application
1.3.1 Global Fostamatinib Market Value by Application: (2024-2034)
1.3.2 Idiopathic (Immune) Thrombocytopenic Purpura
1.3.3 Waldenström's Macroglobulinemia
1.3.4 Autoimmune Haemolytic Anaemia
1.3.5 Other
1.4 Global Fostamatinib Market Size Estimates and Forecasts
1.4.1 Global Fostamatinib Revenue 2018-2034
1.4.2 Global Fostamatinib Sales 2018-2034
1.4.3 Global Fostamatinib Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Fostamatinib Market Competition by Manufacturers
2.1 Global Fostamatinib Sales Market Share by Manufacturers (2018-2023)
2.2 Global Fostamatinib Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Fostamatinib Average Price by Manufacturers (2018-2023)
2.4 Global Fostamatinib Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Fostamatinib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fostamatinib, Product Type & Application
2.7 Fostamatinib Market Competitive Situation and Trends
2.7.1 Fostamatinib Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fostamatinib Players Market Share by Revenue
2.7.3 Global Fostamatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fostamatinib Retrospective Market Scenario by Region
3.1 Global Fostamatinib Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Fostamatinib Global Fostamatinib Sales by Region: 2018-2034
3.2.1 Global Fostamatinib Sales by Region: 2018-2023
3.2.2 Global Fostamatinib Sales by Region: 2024-2034
3.3 Global Fostamatinib Global Fostamatinib Revenue by Region: 2018-2034
3.3.1 Global Fostamatinib Revenue by Region: 2018-2023
3.3.2 Global Fostamatinib Revenue by Region: 2024-2034
3.4 North America Fostamatinib Market Facts & Figures by Country
3.4.1 North America Fostamatinib Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Fostamatinib Sales by Country (2018-2034)
3.4.3 North America Fostamatinib Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fostamatinib Market Facts & Figures by Country
3.5.1 Europe Fostamatinib Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Fostamatinib Sales by Country (2018-2034)
3.5.3 Europe Fostamatinib Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fostamatinib Market Facts & Figures by Country
3.6.1 Asia Pacific Fostamatinib Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Fostamatinib Sales by Country (2018-2034)
3.6.3 Asia Pacific Fostamatinib Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Fostamatinib Market Facts & Figures by Country
3.7.1 Latin America Fostamatinib Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Fostamatinib Sales by Country (2018-2034)
3.7.3 Latin America Fostamatinib Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fostamatinib Market Facts & Figures by Country
3.8.1 Middle East and Africa Fostamatinib Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Fostamatinib Sales by Country (2018-2034)
3.8.3 Middle East and Africa Fostamatinib Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fostamatinib Sales by Type (2018-2034)
4.1.1 Global Fostamatinib Sales by Type (2018-2023)
4.1.2 Global Fostamatinib Sales by Type (2024-2034)
4.1.3 Global Fostamatinib Sales Market Share by Type (2018-2034)
4.2 Global Fostamatinib Revenue by Type (2018-2034)
4.2.1 Global Fostamatinib Revenue by Type (2018-2023)
4.2.2 Global Fostamatinib Revenue by Type (2024-2034)
4.2.3 Global Fostamatinib Revenue Market Share by Type (2018-2034)
4.3 Global Fostamatinib Price by Type (2018-2034)
5 Segment by Application
5.1 Global Fostamatinib Sales by Application (2018-2034)
5.1.1 Global Fostamatinib Sales by Application (2018-2023)
5.1.2 Global Fostamatinib Sales by Application (2024-2034)
5.1.3 Global Fostamatinib Sales Market Share by Application (2018-2034)
5.2 Global Fostamatinib Revenue by Application (2018-2034)
5.2.1 Global Fostamatinib Revenue by Application (2018-2023)
5.2.2 Global Fostamatinib Revenue by Application (2024-2034)
5.2.3 Global Fostamatinib Revenue Market Share by Application (2018-2034)
5.3 Global Fostamatinib Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Rigel Pharmaceuticals, Inc
6.1.1 Rigel Pharmaceuticals, Inc Corporation Information
6.1.2 Rigel Pharmaceuticals, Inc Description and Business Overview
6.1.3 Rigel Pharmaceuticals, Inc Fostamatinib Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Rigel Pharmaceuticals, Inc Fostamatinib Product Portfolio
6.1.5 Rigel Pharmaceuticals, Inc Recent Developments/Updates
6.2 Kissei Pharmaceutical Co., Ltd
6.2.1 Kissei Pharmaceutical Co., Ltd Corporation Information
6.2.2 Kissei Pharmaceutical Co., Ltd Description and Business Overview
6.2.3 Kissei Pharmaceutical Co., Ltd Fostamatinib Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Kissei Pharmaceutical Co., Ltd Fostamatinib Product Portfolio
6.2.5 Kissei Pharmaceutical Co., Ltd Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Fostamatinib Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Grifols Fostamatinib Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 JW Pharmaceutical Corporation
6.4.1 JW Pharmaceutical Corporation Corporation Information
6.4.2 JW Pharmaceutical Corporation Description and Business Overview
6.4.3 JW Pharmaceutical Corporation Fostamatinib Sales, Revenue and Gross Margin (2018-2023)
6.4.4 JW Pharmaceutical Corporation Fostamatinib Product Portfolio
6.4.5 JW Pharmaceutical Corporation Recent Developments/Updates
6.5 Medison Pharma Canada
6.5.1 Medison Pharma Canada Corporation Information
6.5.2 Medison Pharma Canada Description and Business Overview
6.5.3 Medison Pharma Canada Fostamatinib Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Medison Pharma Canada Fostamatinib Product Portfolio
6.5.5 Medison Pharma Canada Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Fostamatinib Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AstraZeneca Fostamatinib Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fostamatinib Industry Chain Analysis
7.2 Fostamatinib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fostamatinib Production Mode & Process
7.4 Fostamatinib Sales and Marketing
7.4.1 Fostamatinib Sales Channels
7.4.2 Fostamatinib Distributors
7.5 Fostamatinib Customers
8 Fostamatinib Market Dynamics
8.1 Fostamatinib Industry Trends
8.2 Fostamatinib Market Drivers
8.3 Fostamatinib Market Challenges
8.4 Fostamatinib Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Fostamatinib Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Fostamatinib Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Fostamatinib Market Competitive Situation by Manufacturers in 2024
Table 4. Global Fostamatinib Sales (K Bottles) of Key Manufacturers (2018-2023)
Table 5. Global Fostamatinib Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Fostamatinib Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Fostamatinib Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Fostamatinib Average Price (US$/Bottle) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Fostamatinib, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Fostamatinib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Fostamatinib, Product Type & Application
Table 12. Global Key Manufacturers of Fostamatinib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Fostamatinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fostamatinib as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Fostamatinib Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Fostamatinib Sales by Region (2018-2023) & (K Bottles)
Table 18. Global Fostamatinib Sales Market Share by Region (2018-2023)
Table 19. Global Fostamatinib Sales by Region (2024-2034) & (K Bottles)
Table 20. Global Fostamatinib Sales Market Share by Region (2024-2034)
Table 21. Global Fostamatinib Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Fostamatinib Revenue Market Share by Region (2018-2023)
Table 23. Global Fostamatinib Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Fostamatinib Revenue Market Share by Region (2024-2034)
Table 25. North America Fostamatinib Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Fostamatinib Sales by Country (2018-2023) & (K Bottles)
Table 27. North America Fostamatinib Sales by Country (2024-2034) & (K Bottles)
Table 28. North America Fostamatinib Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Fostamatinib Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Fostamatinib Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Fostamatinib Sales by Country (2018-2023) & (K Bottles)
Table 32. Europe Fostamatinib Sales by Country (2024-2034) & (K Bottles)
Table 33. Europe Fostamatinib Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Fostamatinib Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Fostamatinib Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Fostamatinib Sales by Region (2018-2023) & (K Bottles)
Table 37. Asia Pacific Fostamatinib Sales by Region (2024-2034) & (K Bottles)
Table 38. Asia Pacific Fostamatinib Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Fostamatinib Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Fostamatinib Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Fostamatinib Sales by Country (2018-2023) & (K Bottles)
Table 42. Latin America Fostamatinib Sales by Country (2024-2034) & (K Bottles)
Table 43. Latin America Fostamatinib Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Fostamatinib Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Fostamatinib Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Fostamatinib Sales by Country (2018-2023) & (K Bottles)
Table 47. Middle East & Africa Fostamatinib Sales by Country (2024-2034) & (K Bottles)
Table 48. Middle East & Africa Fostamatinib Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Fostamatinib Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Fostamatinib Sales (K Bottles) by Type (2018-2023)
Table 51. Global Fostamatinib Sales (K Bottles) by Type (2024-2034)
Table 52. Global Fostamatinib Sales Market Share by Type (2018-2023)
Table 53. Global Fostamatinib Sales Market Share by Type (2024-2034)
Table 54. Global Fostamatinib Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Fostamatinib Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Fostamatinib Revenue Market Share by Type (2018-2023)
Table 57. Global Fostamatinib Revenue Market Share by Type (2024-2034)
Table 58. Global Fostamatinib Price (US$/Bottle) by Type (2018-2023)
Table 59. Global Fostamatinib Price (US$/Bottle) by Type (2024-2034)
Table 60. Global Fostamatinib Sales (K Bottles) by Application (2018-2023)
Table 61. Global Fostamatinib Sales (K Bottles) by Application (2024-2034)
Table 62. Global Fostamatinib Sales Market Share by Application (2018-2023)
Table 63. Global Fostamatinib Sales Market Share by Application (2024-2034)
Table 64. Global Fostamatinib Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Fostamatinib Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Fostamatinib Revenue Market Share by Application (2018-2023)
Table 67. Global Fostamatinib Revenue Market Share by Application (2024-2034)
Table 68. Global Fostamatinib Price (US$/Bottle) by Application (2018-2023)
Table 69. Global Fostamatinib Price (US$/Bottle) by Application (2024-2034)
Table 70. Rigel Pharmaceuticals, Inc Corporation Information
Table 71. Rigel Pharmaceuticals, Inc Description and Business Overview
Table 72. Rigel Pharmaceuticals, Inc Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 73. Rigel Pharmaceuticals, Inc Fostamatinib Product
Table 74. Rigel Pharmaceuticals, Inc Recent Developments/Updates
Table 75. Kissei Pharmaceutical Co., Ltd Corporation Information
Table 76. Kissei Pharmaceutical Co., Ltd Description and Business Overview
Table 77. Kissei Pharmaceutical Co., Ltd Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 78. Kissei Pharmaceutical Co., Ltd Fostamatinib Product
Table 79. Kissei Pharmaceutical Co., Ltd Recent Developments/Updates
Table 80. Grifols Corporation Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 83. Grifols Fostamatinib Product
Table 84. Grifols Recent Developments/Updates
Table 85. JW Pharmaceutical Corporation Corporation Information
Table 86. JW Pharmaceutical Corporation Description and Business Overview
Table 87. JW Pharmaceutical Corporation Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 88. JW Pharmaceutical Corporation Fostamatinib Product
Table 89. JW Pharmaceutical Corporation Recent Developments/Updates
Table 90. Medison Pharma Canada Corporation Information
Table 91. Medison Pharma Canada Description and Business Overview
Table 92. Medison Pharma Canada Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 93. Medison Pharma Canada Fostamatinib Product
Table 94. Medison Pharma Canada Recent Developments/Updates
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 98. AstraZeneca Fostamatinib Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Fostamatinib Distributors List
Table 103. Fostamatinib Customers List
Table 104. Fostamatinib Market Trends
Table 105. Fostamatinib Market Drivers
Table 106. Fostamatinib Market Challenges
Table 107. Fostamatinib Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Fostamatinib
Figure 2. Global Fostamatinib Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Fostamatinib Market Share by Type in 2024 & 2034
Figure 4. Tavalisse Product Picture
Figure 5. Tavlesse Product Picture
Figure 6. Global Fostamatinib Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Fostamatinib Market Share by Application in 2024 & 2034
Figure 8. Idiopathic (Immune) Thrombocytopenic Purpura
Figure 9. Waldenström's Macroglobulinemia
Figure 10. Autoimmune Haemolytic Anaemia
Figure 11. Other
Figure 12. Global Fostamatinib Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Fostamatinib Market Size (2018-2034) & (US$ Million)
Figure 14. Global Fostamatinib Sales (2018-2034) & (K Bottles)
Figure 15. Global Fostamatinib Average Price (US$/Bottle) & (2018-2034)
Figure 16. Fostamatinib Report Years Considered
Figure 17. Fostamatinib Sales Share by Manufacturers in 2024
Figure 18. Global Fostamatinib Revenue Share by Manufacturers in 2024
Figure 19. The Global 5 and 10 Largest Fostamatinib Players: Market Share by Revenue in 2024
Figure 20. Fostamatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 21. Global Fostamatinib Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 22. North America Fostamatinib Sales Market Share by Country (2018-2034)
Figure 23. North America Fostamatinib Revenue Market Share by Country (2018-2034)
Figure 24. United States Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Fostamatinib Sales Market Share by Country (2018-2034)
Figure 27. Europe Fostamatinib Revenue Market Share by Country (2018-2034)
Figure 28. Germany Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Fostamatinib Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Fostamatinib Revenue Market Share by Region (2018-2034)
Figure 35. China Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. China Taiwan Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Fostamatinib Sales Market Share by Country (2018-2034)
Figure 45. Latin America Fostamatinib Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Fostamatinib Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Fostamatinib Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Fostamatinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Fostamatinib by Type (2018-2034)
Figure 55. Global Revenue Market Share of Fostamatinib by Type (2018-2034)
Figure 56. Global Fostamatinib Price (US$/Bottle) by Type (2018-2034)
Figure 57. Global Sales Market Share of Fostamatinib by Application (2018-2034)
Figure 58. Global Revenue Market Share of Fostamatinib by Application (2018-2034)
Figure 59. Global Fostamatinib Price (US$/Bottle) by Application (2018-2034)
Figure 60. Fostamatinib Value Chain
Figure 61. Fostamatinib Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed